PhyPharm is an independent sales and market-access agency for medical cannabis, based in Germany. We help producers and wholesalers enter and grow in the German and European market.
Germany is the largest medical cannabis market in Europe and also the most formal one. Producers rarely fail on the product itself; they fail on the chain behind it: wholesale partner, documentation, pricing and ongoing contact with pharmacies.
PhyPharm works as a sales agency for producers in this market and gives pharmacies, physicians and licensed distributors a single point of contact to quality-assured medical cannabis from established supply partners.
A sober view of portfolio, potency ranges, available volumes, certificates and price expectations — and whether an entry into Germany or other EU markets makes sense, and in which segment.
Preparing product documentation that German pharmacies can work with from day one: EU-GMP, Ph. Eur./DAB, certificates of analysis, German-language product information and PZN assignment.
Building and managing the connection to German wholesalers with the required licences, and approaching pharmacies and pharmacy groups for listing.
A price structure that fits wholesaler and pharmacy margins, launch support and ongoing feedback from the market after the listing.
Leadership in purchasing, private label and sales management — including scaling a private-label division from €0.8bn to €1.2bn in revenue at a globally operating retail chain, with international sourcing and sales management.
Building international cannabis businesses and market entries across Europe, from regulatory tenders to product launch. Mandates include building Columbia Care's European business and Germany's first cultivation licences in the BfArM tender (Aurora / MedReleaf).
The perspective is that of the buyer on the other side of the table. References and reference letters are available on request.